An update of peritonectomy procedures used in cytoreductive surgery for peritoneal malignancy

References

• Lambert LA. Looking up: recent advances in understanding and treating peritoneal carcinomatosis. CA Cancer J Clin. 2015;65:284–298.
   PubMed Web of Science ®Google Scholar
• Franko J, Shi Q, Meyers JP, et al. Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database. Lancet Oncol. 2016;17:1709–1719.
   PubMed Web of Science ®Google Scholar
• Verwaal VJ, van Ruth S, de Bree E, et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol. 2003;21:3737–3743.
   PubMed Web of Science ®Google Scholar
• Yang XJ, Huang CQ, Suo T, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial. Ann Surg Oncol. 2011;18:1575–1581.
   PubMed Web of Science ®Google Scholar
• Yan TD, Deraco M, Baratti D, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience. J Clin Oncol. 2009;27:6237–6242.
   PubMed Web of Science ®Google Scholar
• Chua TC, Moran BJ, Sugarbaker PH, et al. Early- and long-term outcome data of patients with Pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol. 2012;30:2449–2456.
   PubMed Web of Science ®Google Scholar
• van Driel WJ, Koole SN, Sikorska K, et al. Hyperthermic intraperitoneal chemotherapy in ovarian cancer. N Engl J Med. 2018;378:230–240.
   PubMed Web of Science ®Google Scholar
• Jacquet P, Sugarbaker PH. Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res. 1996;82:359–374.
   PubMedGoogle Scholar
• Sugarbaker PH. Peritonectomy procedures. Ann Surg. 1995;221:29–42.
   PubMed Web of Science ®Google Scholar
• Dagbert F, Passot G, Glehen O, et al. Glisson capsulectomy for extensive superficial liver involvement in peritoneal carcinomatosis (with video). J Vis Surg. 2015;152:332–333.
   Web of Science ®Google Scholar
• Passot G, Kim BJ, Vaudoyer D, et al. Digital glissonectomy: a safe perihepatic peritonectomy. Ann Surg Oncol. 2016;23:3978–3985.
   PubMed Web of Science ®Google Scholar
• Deraco M, Baratti D, Kusamura S, et al. Surgical technique of parietal and visceral peritonectomy for peritoneal surface malignancies. J Surg Oncol. 2009;100:321–328.
   PubMed Web of Science ®Google Scholar
• Cazauran JB, Lasseur A, Pasquer A, et al. Total mesenteric peritonectomy for peritoneal metastases (with video). Ann Surg Oncol. 2017;24:3988–3989.
   PubMed Web of Science ®Google Scholar
• Deraco M, Glehen O, Helm CW, et al. An overview of peritonectomy, visceral resections, and perioperative chemotherapy for peritoneal surface malignancy. In: Sugarbaker PH, editor. Cytoreductive surgery & perioperative chemotherapy for peritoneal surface malignancy. Woodbury (CT): Ciné-Med; 2013.
   Google Scholar
• Elias D, Gilly F, Boutitie F, et al. Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study. J Clin Oncol. 2010;28:63–68.
   PubMed Web of Science ®Google Scholar
• Sugarbaker PH. Avoiding diverting ileostomy in patients requiring complete pelvic peritonectomy. Ann Surg Oncol. 2016;23:1481–1485.
   PubMed Web of Science ®Google Scholar
• Banaste N, Rousset P, Mercier F, et al. Preoperative nutritional risk assessment in patients undergoing cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for colorectal carcinomatosis. Int J Hyperthermia. 2018;34:589–594.
   PubMed Web of Science ®Google Scholar
• Cavalheri V, Granger C. Preoperative exercise training for patients with non-small cell lung cancer. Cochrane Database Syst Rev. 2017;6:CD012020.
   PubMed Web of Science ®Google Scholar
• Snowdon D, Haines TP, Skinner EH. Preoperative intervention reduces postoperative pulmonary complications but not length of stay in cardiac surgical patients: a systematic review. J Physiother. 2014;60:66–77.
   PubMed Web of Science ®Google Scholar
• Sugarbaker PH. It’s what the surgeon doesn't see that kills the patient. J Nippon Med Sch. 2000;67:5–8.
   PubMedGoogle Scholar
• Baumgartner JM, Tobin L, Heavey SF, et al. Predictors of progression in high-grade appendiceal or colorectal peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2015;22:1716–1721.
   PubMed Web of Science ®Google Scholar
• Bakrin N, Bereder JM, Decullier E, et al. Peritoneal carcinomatosis treated with cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for advanced ovarian carcinoma: a French multicentre retrospective cohort study of 566 patients. Eur J Surg Oncol. 2013;39:1435–1443.
   PubMed Web of Science ®Google Scholar
• Miner TJ, Shia J, Jaques DP, et al. Long-term survival following treatment of Pseudomyxoma peritonei: an analysis of surgical therapy. Ann Surg. 2005;241:300–308.
   PubMed Web of Science ®Google Scholar
• Canbay E, Mizumoto A, Ichinose M, et al. Outcome data of patients with peritoneal carcinomatosis from gastric origin treated by a strategy of bidirectional chemotherapy prior to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a single specialized center in Japan. Ann Surg Oncol. 2014;21:1147–1152.
   PubMed Web of Science ®Google Scholar
• Mercier F, Passot G, Villeneuve L, et al. Peritoneal carcinomatosis of urachus origin treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC): an international registry of 36 patients. Ann Surg Oncol. 2018;25:1094–1100.
   PubMed Web of Science ®Google Scholar
• Passot G, Vaudoyer D, Villeneuve L, et al. A perioperative clinical pathway can dramatically reduce failure-to-rescue rates after cytoreductive surgery for peritoneal carcinomatosis: a retrospective study of 666 consecutive cytoreductions. Ann Surg. 2017;265:806–813.
   PubMed Web of Science ®Google Scholar
• Passot G, Bakrin N, Roux AS, et al. Quality of life after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy: a prospective study of 216 patients. Eur J Surg Oncol. 2014;40:529–535.
   PubMed Web of Science ®Google Scholar
• Dagbert F, Thievenaz R, Decullier E, et al. Splenectomy increases postoperative complications following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2016;23:1980–1985.
   PubMed Web of Science ®Google Scholar
• Schwarz L, Votanopoulos K, Morris D, et al. Is the combination of distal pancreatectomy and cytoreductive surgery with HIPEC reasonable? Results of an International Multicenter Study. Ann Surg. 2016;263:369–375.
   PubMed Web of Science ®Google Scholar
• Evers DJ, Smeenk RM, Bottenberg PD, et al. Effect of preservation of the right gastro-epiploic artery on delayed gastric emptying after cytoreductive surgery and HIPEC: a randomized clinical trial. Eur J Surg Oncol. 2011;37:162–167.
   PubMed Web of Science ®Google Scholar
• Glehen O, Mohamed F, Gilly FN. Peritoneal carcinomatosis from digestive tract cancer: new management by cytoreductive surgery and intraperitoneal chemohyperthermia. Lancet Oncol. 2004;5:219–228.
   PubMed Web of Science ®Google Scholar
• Karoui M, Tayar C, Laurent A, et al. En bloc stapled diaphragmatic resection for local invasion during hepatectomy: a simple technique without opening the pleural cavity. Am J Surg. 2007;193:786–788.
   PubMed Web of Science ®Google Scholar
• Sugarbaker PH. Peritoneal metastases invading the seminal vesicles: radiologic appearance and outcome of treatment. Eur J Surg Oncol. 2018;44:805–809.
   PubMed Web of Science ®Google Scholar
• Elias D, Borget I, Farron M, et al. Prognostic significance of visible cardiophrenic angle lymph nodes in the presence of peritoneal metastases from colorectal cancers. Eur J Surg Oncol. 2013;39:1214–1218.
   PubMed Web of Science ®Google Scholar
• Cowan RA, Tseng J, Murthy V, et al. Feasibility, safety and clinical outcomes of cardiophrenic lymph node resection in advanced ovarian cancer. Gynecol Oncol. 2017;147:262–266.
   PubMed Web of Science ®Google Scholar
• Passot G, Vaudoyer D, Villeneuve L, et al. What made hyperthermic intraperitoneal chemotherapy an effective curative treatment for peritoneal surface malignancy: a 25-year experience with 1,125 procedures. J Surg Oncol. 2016;113:796–803.
   PubMed Web of Science ®Google Scholar
• Kusamura S, Gonzalez-Moreno S, Nizri E, et al. Learning curve, training program, and monitorization of surgical performance of peritoneal surface malignancies centers. Surg Oncol Clin N Am. 2018;27:507–517.
   PubMed Web of Science ®Google Scholar